CRMD CorMedix Inc.Stock Price & Overview
$5.84
Charts
Quant Ranking
CRMD Analysis
CRMD News
Latest Headlines
Ratings Summary
People Also Follow
Similar to CRMD
ETFs Holding CRMD
CRMD Company Profile
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
CRMD Revenue
CRMD Earnings Per Share
Earnings Estimates
Earnings Revisions
Valuation
Growth
Profitability
Momentum
Capital Structure
Dividends
CRMD Ownership
CRMD Peers
Risk
Technicals
CRMD Transcripts
Investor Presentations
CRMD SEC Filings
Press Releases
CRMD Income Statement
CRMD Balance Sheet
CRMD Cash Flow Statement
CRMD Long Term Solvency
Discover More
You may be interested in: